The Spain Disposable Endoscopes Market was valued at $5.7 Million in 2025 and projected to reach to $15.9 Million by 2030, representing a compound annual growth rate of 22.7%. Spain's disposable endoscopes market is positioned for sustained high-growth expansion through 2030, driven by healthcare system modernization and heightened infection control standards.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Spain's disposable endoscopes market is growing at 22.7% CAGR, significantly outpacing traditional reusable device adoption. The market is projected to nearly triple from USD 5.7 million in 2025 to USD 15.9 million by 2030, driven by healthcare modernization initiatives across Spanish medical institutions.
Spanish hospitals and diagnostic centers are increasingly prioritizing infection prevention through single-use endoscopic devices. Post-pandemic awareness has elevated the demand for disposable endoscopes as healthcare facilities invest in reducing cross-contamination risks and improving patient safety protocols.
Spain's modernization of healthcare infrastructure is accelerating adoption of advanced diagnostic technologies. Public and private healthcare providers are upgrading endoscopy departments with disposable alternatives, supported by government healthcare spending initiatives and EU funding programs.
The expansion of private diagnostic centers and outpatient endoscopy facilities across Spain is creating new demand vectors for disposable endoscopes. These facilities prioritize operational efficiency and infection control, making single-use devices an attractive alternative to traditional sterilization-dependent equipment.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | GI ENDOSCOPES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 22.9% from 2025 to 2030 |
| Largest Segment | UROLOGY ENDOSCOPES (Type) |
| Market Size Base Year (Billions) | ~USD 0.95 (2025) |
| Revenue Forecast (Billions) | ~USD 2.67 (2030) |
| Segments Covered | Type |
1 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 3.3 | 3.9 | 4.6 | 5.6 | 6.9 | 8.8 | 11.5 | 15.3 | 27.3 |
| CLINICS | 2.2 | 2.5 | 2.8 | 3.3 | 4 | 4.8 | 6.1 | 7.8 | 22.2 |
| HOSPITALS | 10.2 | 11.3 | 12.4 | 14 | 16.3 | 19.3 | 23.5 | 29.3 | 18.7 |
| OTHER END USERS | 2.7 | 3 | 3.4 | 3.9 | 4.5 | 5.5 | 6.8 | 8.6 | 20.8 |
| TOTAL | 18.4 | 20.7 | 23.2 | 26.8 | 31.7 | 38.5 | 47.9 | 60.9 | 21.3 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AMBU A/S | Denmark | Public Company | GI Endoscopes,Urology Endoscopes,Laryngoscopes & Bronchoscopes, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | GI Endoscopes (SpyGlass, single-use duodenoscopes, related GI disposables),Urology Endoscopes (single-use digital flexible ureteroscopes),Laryngoscopes and ENT-related single-use scopes, |
| OLYMPUS CORPORATION | Japan | Public Company | GI Disposable Endoscopes,Urology Disposable Endoscopes,Laryngoscopes / ENT Disposable Endoscopes, |
| HOYA CORPORATION | Japan | Public Company | GI Endoscopes,Urology Endoscopes,Laryngoscopes / ENT Endoscopes, |
| THE COOPER COMPANIES, INC. | United States | Public Company | GI Endoscopes,Urology Endoscopes,Laryngoscopes, |
| OTU MEDICAL | United States | Public Company | GI Endoscopes,Urology Endoscopes,Laryngoscopes, |
AMBU A/S is a Danish medical device company founded in 1937 with 5,200 employees. Operating as a public company, it serves the global healthcare market.
Boston Scientific Corporation is a United States-based medical device manufacturer founded in 1979 with 59,000 employees. The publicly traded company is a major player in the global medical technology industry.
Olympus Corporation is a Japanese multinational company founded in 1919 with 28,138 employees. As a public company, it operates across multiple sectors including medical devices and imaging technology.
HOYA Corporation is a Japanese public company founded in 1941 with 37,752 employees. The company operates in healthcare, optical products, and related technology sectors.
The Cooper Companies, Inc. is a United States-based public company founded in 1960 with 18,000 employees. The company operates in the medical device and healthcare sectors.
OTU Medical is a United States-based public company founded in 1984 with 13,000 employees. The company operates in the medical device and healthcare industry.
Spain's disposable endoscopes market was valued at USD 5.7 million in 2025 and is expected to grow significantly through 2030.
Spain's disposable endoscopes market is forecasted to reach USD 15.9 million by 2030, representing nearly triple the 2025 valuation.
Spain's disposable endoscopes market is projected to grow at a compound annual growth rate of 22.7% from 2025 to 2030.
Spain's market growth is driven by aging demographics, rising gastrointestinal disease prevalence, infection control priorities, and healthcare modernization initiatives.
Spain's 22.7% CAGR positions it as a high-growth market within Europe, reflecting strong healthcare infrastructure and adoption of advanced endoscopic technologies.
The research study involved key activities in estimating the current market size for disposable endoscopes. Extensive secondary research was conducted to collect information on the market. The next step was to validate these findings, assumptions, and estimates with industry experts across the value chain using primary research. Different methods, such as top-down and bottom-up approaches, were used to calculate the total market size. Following that, market segmentation and data triangulation procedures were employed to determine the market size of the segments and subsegments of the disposable endoscopes market.
The secondary research process involved extensive use of secondary sources, including directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies, and publications from government agencies like the National Institutes of Health (NIH), US Food and Drug Administration (FDA), US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS). These sources were used to identify and gather information for the global disposable endoscopes market study. They also provided essential details about key players, market classification, and segmentation based on industry trends down to the most detailed levels, as well as key developments related to market and technology perspectives. Additionally, a database of leading industry players was created using secondary sources research.
During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from various companies and organizations in the disposable endoscopes market. On the demand side, sources include ambulatory surgical centers, hospitals, clinics, and other end users. This primary research was conducted to validate market segmentation, identify key players, and gather insights on major industry trends and market dynamics.
A breakdown of the primary respondents is provided below:
C-level primaries include CEOs, CFOs, COOs, and VPs.
*Others include Sales Managers, Marketing Managers, Business Development Managers, Product Managers, Distributors, and Suppliers.
Companies are classified into tiers based on their total revenue. The tiers are as follows:
Tier 1 = > USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenue figures were calculated based on revenue mapping of major product manufacturers and OEMs active in the worldwide disposable endoscopes market. All major product manufacturers were identified at the global and/or country or regional level. Revenue mapping for the relevant business segments or sub-segments was conducted for the key players. Additionally, the global disposable endoscopes market was divided into various segments and sub-segments based on,
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After determining the overall size of the global disposable endoscopes market using the methodology described above, this market was divided into several segments and subsegments. Data triangulation and market segmentation techniques were used, where applicable, to complete the entire market analysis and obtain precise market value data for the key segments and subsegments. The estimated market data was validated by analyzing various macro indicators and regional trends from both demand and supply perspectives.
Disposable endoscopes are single-use medical devices designed for diagnostic and therapeutic procedures that provide direct visualization of internal organs. These sterile, ready-to-use instruments eliminate the need for reprocessing, reduce infection risks, and improve operational efficiency across various specialties such as gastroenterology, urology, pulmonology, and otolaryngology.
Full forecast, segment splits, and company analysis for all Disposable Endoscopes Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report